Crossref journal-article
S. Karger AG
European Neurology (127)
Abstract

Significantly elevated plasma levels of homocysteine, but not cysteine and cysteinylglycine, were found in treated parkinsonian patients compared to controls. Elevated levels of homocysteine may be either caused by an unknown endogenous metabolic disturbance or by antiparkinsonian treatment, because no association to severity or duration of disease was found. Based on the results of this study one may speculate that homocysteine may be an independent risk factor for vascular disease in Parkinson’s disease.

Bibliography

Kuhn, W., Roebroek, R., Blom, H., van Oppenraaij, D., Przuntek, H., Kretschmer, A., Büttner, T., Woitalla, D., & Müller, T. (1998). Elevated Plasma Levels of Homocysteine inParkinson’s Disease. European Neurology, 40(4), 225–227. Portico.

Authors 9
  1. W. Kuhn (first)
  2. R. Roebroek (additional)
  3. H. Blom (additional)
  4. D. van Oppenraaij (additional)
  5. H. Przuntek (additional)
  6. A. Kretschmer (additional)
  7. T. Büttner (additional)
  8. D. Woitalla (additional)
  9. T. Müller (additional)
Dates
Type When
Created 22 years, 4 months ago (April 15, 2003, 11:42 a.m.)
Deposited 4 months, 1 week ago (April 24, 2025, 12:42 a.m.)
Indexed 4 weeks, 2 days ago (Aug. 6, 2025, 8:47 a.m.)
Issued 27 years, 8 months ago (Jan. 1, 1998)
Published 27 years, 8 months ago (Jan. 1, 1998)
Published Online 26 years, 9 months ago (Nov. 20, 1998)
Published Print 27 years, 8 months ago (Jan. 1, 1998)
Funders 0

None

@article{Kuhn_1998, title={Elevated Plasma Levels of Homocysteine inParkinson’s Disease}, volume={40}, ISSN={1421-9913}, url={http://dx.doi.org/10.1159/000007984}, DOI={10.1159/000007984}, number={4}, journal={European Neurology}, publisher={S. Karger AG}, author={Kuhn, W. and Roebroek, R. and Blom, H. and van Oppenraaij, D. and Przuntek, H. and Kretschmer, A. and Büttner, T. and Woitalla, D. and Müller, T.}, year={1998}, pages={225–227} }